FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.3  |  FHIR Version n/a  User: [n/a]

387208003: Isotretinoin (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1461386011 Isotretinoin (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1481313017 Isotretinoin en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1491926011 13-cis-Retinoic acid en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
4498521000005114 Isotretinoin da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Isotretinoin (substance) Is a Retinoid (substance) true Inferred relationship Some
Isotretinoin (substance) Is a Tretinoin (substance) false Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Isotretinoin measurement Component True Isotretinoin (substance) Inferred relationship Some 1
Isotretinoin adverse reaction (disorder) Causative agent True Isotretinoin (substance) Inferred relationship Some 1
Allergy to isotretinoin Causative agent False Isotretinoin (substance) Inferred relationship Some
Isotretinoin overdose Causative agent True Isotretinoin (substance) Inferred relationship Some 1
Accidental isotretinoin overdose Causative agent True Isotretinoin (substance) Inferred relationship Some 1
Intentional isotretinoin overdose Causative agent True Isotretinoin (substance) Inferred relationship Some 1
overdosis af isotretinion, uvist med hvilken hensigt Causative agent False Isotretinoin (substance) Inferred relationship Some 1
Isotretinoin [topical] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Isotretinoin (substance) Inferred relationship Some
Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Isotretinoin (substance) Inferred relationship Some
Product containing precisely isotretinoin 5 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Isotretinoin (substance) Inferred relationship Some
Product containing precisely isotretinoin 20 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Isotretinoin (substance) Inferred relationship Some
Product containing precisely isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Isotretinoin (substance) Inferred relationship Some
Retinoinsyreembryopati Causative agent False Isotretinoin (substance) Inferred relationship Some
Product containing precisely isotretinoin 10 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Isotretinoin (substance) Inferred relationship Some
Product containing precisely isotretinoin 40 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Isotretinoin (substance) Inferred relationship Some
Product containing isotretinoin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Isotretinoin (substance) Inferred relationship Some 1
Product containing erythromycin and isotretinoin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Isotretinoin (substance) Inferred relationship Some 2
Isotretinoin 30 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Isotretinoin (substance) Inferred relationship Some
isotretinoin til topikal anvendelse The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Isotretinoin (substance) Inferred relationship Some
Product containing isotretinoin in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Isotretinoin (substance) Inferred relationship Some 1
Allergy to isotretinoin Causative agent True Isotretinoin (substance) Inferred relationship Some 1
Isotretinoin therapy (procedure) Direct substance True Isotretinoin (substance) Inferred relationship Some 2
Product containing precisely isotretinoin 5 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Isotretinoin (substance) Inferred relationship Some 1
Product containing precisely isotretinoin 5 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Isotretinoin (substance) Inferred relationship Some 1
Product containing precisely isotretinoin 20 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Isotretinoin (substance) Inferred relationship Some 1
Product containing precisely isotretinoin 20 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Isotretinoin (substance) Inferred relationship Some 1
Product containing precisely isotretinoin 10 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Isotretinoin (substance) Inferred relationship Some 1
Product containing precisely isotretinoin 10 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Isotretinoin (substance) Inferred relationship Some 1
Product containing precisely isotretinoin 40 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Isotretinoin (substance) Inferred relationship Some 1
Product containing precisely isotretinoin 40 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Isotretinoin (substance) Inferred relationship Some 1
Isotretinoin 30 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Isotretinoin (substance) Inferred relationship Some 1
Isotretinoin 30 mg oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Isotretinoin (substance) Inferred relationship Some 1
Product containing precisely isotretinoin 10 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Isotretinoin (substance) Inferred relationship Some 1
Product containing precisely isotretinoin 5 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Isotretinoin (substance) Inferred relationship Some 1
Product containing precisely isotretinoin 20 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Isotretinoin (substance) Inferred relationship Some 1
Product containing precisely isotretinoin 40 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Isotretinoin (substance) Inferred relationship Some 1
Isotretinoin 30 mg oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Isotretinoin (substance) Inferred relationship Some 1
Product containing precisely isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Isotretinoin (substance) Inferred relationship Some 1
Product containing precisely isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Isotretinoin (substance) Inferred relationship Some 1
Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Isotretinoin (substance) Inferred relationship Some 1
Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Isotretinoin (substance) Inferred relationship Some 1
Isotretinoin-containing product in cutaneous dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Isotretinoin (substance) Inferred relationship Some 1
Erythromycin- and isotretinoin-containing product in cutaneous dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Isotretinoin (substance) Inferred relationship Some 2
Erythromycin and isotretinoin only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Isotretinoin (substance) Inferred relationship Some 2
Isotretinoin only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Isotretinoin (substance) Inferred relationship Some 1
Product containing only isotretinoin in cutaneous dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Isotretinoin (substance) Inferred relationship Some 1
Isotretinoin only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Isotretinoin (substance) Inferred relationship Some 1
Erythromycin and isotretinoin only product in cutaneous dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Isotretinoin (substance) Inferred relationship Some 2
Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Isotretinoin (substance) Inferred relationship Some 2
Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Isotretinoin (substance) Inferred relationship Some 2
A rare teratogenic embryofetopathy due to exposure to isotretinoin, an oral synthetic vitamin A derivative, which is used to treat severe recalcitrant cystic acne. Exposure to isotretinoin during the first trimester of pregnancy has been associated with an increased risk of spontaneous abortions and severe birth defects including serious craniofacial (microcephaly, asymmetric crying facies, microphthalmia, developmental abnormalities of the external ear, ocular hypertelorism), cardiovascular (conotruncal heart defects, aortic arch abnormalities), and central nervous system (hydrocephalus, microcephaly, lissencephaly, Dandy-Walker malformation, cognitive deficit) anomalies and thymic aplasia. Causative agent True Isotretinoin (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start